Researchers conducted a prospective, observational study to explore the impact of nutritional status prior to cancer treatment initiation and mortality risk.
Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results